Inventiva (IVA) Asset Writedowns and Impairment (2022 - 2024)
Inventiva's (IVA) quarterly Asset Writedowns and Impairment came in at -$9692.0 in Q2 2024, up 73.03% year-on-year from -$5601.4 in Q3 2023, and little changed quarter-over-quarter from -$9683.5 in Q4 2023.
Inventiva (IVA) Asset Writedowns and Impairment (2022 - 2024) Analysis & Trends
Inventiva's Asset Writedowns and Impairment history runs 3 years deep, the most recent figure standing at -$9692.0 for Q2 2024.
- On a quarterly basis, Asset Writedowns and Impairment rose 73.03% year-over-year to -$9692.0 in Q2 2024; TTM through Jun 2024 was -$9692.0, a 73.03% increase from a year earlier, with the FY2023 full-year figure at -$9683.5, up 71.24% from the prior year.
- Asset Writedowns and Impairment was little changed at -$9692.0 in Q2 2024 per IVA's latest filing, from -$9683.5 in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at -$9683.5 in Q4 2023 and bottomed at -$35934.5 in Q2 2023.
- The 3-year median for Asset Writedowns and Impairment is -$21680.1 (2022), against an average of -$22244.5.
- Across the five-year window, Asset Writedowns and Impairment soared 71.24% in 2023 and jumped 73.03% in 2024, its largest moves.
- Year by year, Asset Writedowns and Impairment stood at -$33668.2 in 2022, then soared by 71.24% to -$9683.5 in 2023, then retreated by 0.09% to -$9692.0 in 2024.
- Per Business Quant, the three latest IVA Asset Writedowns and Impairment figures stand at -$9692.0 (Q2 2024), -$9683.5 (Q4 2023), and -$35934.5 (Q2 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Inventiva | 854.62 Mn | 854.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -9,691.99 |
| Jun 30, 2024 | -9,691.99 |
| Dec 31, 2023 | -9,683.46 |
| Dec 31, 2023 | -9,683.46 |
| Jun 30, 2023 | -35,934.50 |
| Jun 30, 2023 | -35,934.50 |
| Dec 31, 2022 | -33,668.16 |
| Dec 31, 2022 | -33,668.16 |